[Skip to Content]
[Skip to Content Landing]
Citations 0
June 2, 1999

Screening for Type 2 Diabetes

Author Affiliations

Margaret A.WinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor

JAMA. 1999;281(21):1986-1988. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-21-jbk0602

To the Editor: Simulation modeling is a powerful and appropriate tool for examining the possible impact of screening for type 2 diabetes, and we agree with the conclusion of the CDC Diabetes Cost-Effectiveness Study Group that "the selection of appropriate target populations for screening should consider factors in addition to the prevalence of diabetes."1 However, we are concerned that their model disregards some of the important factors that influence outcomes.

First Page Preview View Large
First page PDF preview
First page PDF preview